COMP <GO>
BSX vs BDX // DIVIDEND YIELD & FCF PAYOUT SAFETY
Boston Scientific Corporation (NYSE) VS. Becton Dickinson and Company (NYSE) • 15-METRIC TALLY: BSX 10
— BDX 3
▲ DIVIDEND YIELD & FCF PAYOUT SAFETY LEADER: BDX
LAST: $41.98 (-1.66%) • MKT CAP: $61.87B
dividend-safety
0.00%
LAST: $197.88 (-0.23%) • MKT CAP: $54.03B
dividend-safety
2.21%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BSX VS. BDX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BSX | BDX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 69.00% | 45.40% | +23.60 | BSX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.20% | 4.90% | +4.30 | BSX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 15.8x | 21.8x | -6.00 | BSX | /valuation <GO> |
| Free Cash Flow Yield | 5.91% | 2.13% | +3.78 | BSX | /fcf-yield <GO> |
| Operating Margin | 18.00% | 11.80% | +6.20 | BSX | /operating-margins <GO> |
| Net Profit Margin | 14.00% | 7.70% | +6.30 | BSX | /net-margins <GO> |
| Revenue Growth (YoY) | 19.90% | 8.20% | +11.70 | BSX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 2.21% | -2.21 | BDX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.77 | 2.22 | +0.55 | BSX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.0 | 64.6 | -21.60 | BDX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.99 | 1.06 | -0.07 | BDX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.5x | 29.9x | -11.40 | BSX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $61.87B | $54.03B | $7.84B | BSX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BSX REV | BDX REV | BSX GROSS % | BDX GROSS % | BSX FCF | BDX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $20.07B | $21.84B | 69.0% | 45.4% | $3.66B | — |
| FY 2024 | $16.75B | $20.18B | 68.6% | 45.2% | $2.65B | — |
| FY 2023 | $14.24B | $19.37B | — | — | $1.86B | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BSX // BETA 0.99
BDX // BETA 1.06